Hu 210: a potent tool for investigations of the cannabinoid system
- PMID: 11474421
- PMCID: PMC6741702
- DOI: 10.1111/j.1527-3458.2001.tb00192.x
Hu 210: a potent tool for investigations of the cannabinoid system
Abstract
The synthetic compound HU 210 displays a multiplicity of biochemical, pharmacological, and behavioral effects, most of which have been demonstrated to be dependent on a selective agonistic activity at CB(1) and CB(2) cannabinoid receptors and to involve the main neurotransmitter systems. Results obtained in various studies suggest a potential clinical application of this highly potent drug (e.g., as antipyretic, antiinflammatory, analgesic, antiemetic, and antipsychotic agent) as well as its usefulness in research aimed to develop a better understanding of the involvement of the endogenous cannabinoid system in a number of physiopathological functions.
Similar articles
-
Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists.Neuropharmacology. 2010 Nov;59(6):503-10. doi: 10.1016/j.neuropharm.2010.07.005. Epub 2010 Jul 13. Neuropharmacology. 2010. PMID: 20633567
-
Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.Eur J Pharmacol. 2001 Jul 6;423(2-3):203-10. doi: 10.1016/s0014-2999(01)01112-8. Eur J Pharmacol. 2001. PMID: 11448486
-
Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.Pharmacol Biochem Behav. 2002 Jan-Feb;71(1-2):155-62. doi: 10.1016/s0091-3057(01)00647-5. Pharmacol Biochem Behav. 2002. PMID: 11812518
-
Therapeutic potential of cannabinoids in CNS disease.CNS Drugs. 2003;17(3):179-202. doi: 10.2165/00023210-200317030-00004. CNS Drugs. 2003. PMID: 12617697 Review.
-
Behavioral effects of cannabinoid agents in animals.Crit Rev Neurobiol. 1999;13(3):243-81. doi: 10.1615/critrevneurobiol.v13.i3.20. Crit Rev Neurobiol. 1999. PMID: 10803637 Review.
Cited by
-
The effect of schizophrenia risk factors on mismatch responses in a rat model.Psychophysiology. 2023 Feb;60(2):e14175. doi: 10.1111/psyp.14175. Epub 2022 Sep 10. Psychophysiology. 2023. PMID: 36087044 Free PMC article.
-
Pharmacokinetics and pharmacodynamics of cannabinoids.Clin Pharmacokinet. 2003;42(4):327-60. doi: 10.2165/00003088-200342040-00003. Clin Pharmacokinet. 2003. PMID: 12648025 Review.
-
Alteration of imprinted Dlk1-Dio3 miRNA cluster expression in the entorhinal cortex induced by maternal immune activation and adolescent cannabinoid exposure.Transl Psychiatry. 2014 Sep 30;4(9):e452. doi: 10.1038/tp.2014.99. Transl Psychiatry. 2014. PMID: 25268256 Free PMC article.
-
HU210-induced downregulation in cannabinoid CB1 receptor binding strongly correlates with body weight loss in the adult rat.Neurochem Res. 2009 Jul;34(7):1343-53. doi: 10.1007/s11064-009-9914-y. Epub 2009 Jan 24. Neurochem Res. 2009. PMID: 19169813
-
Chronic endocannabinoid system stimulation induces muscle macrophage and lipid accumulation in type 2 diabetic mice independently of metabolic endotoxaemia.PLoS One. 2013;8(2):e55963. doi: 10.1371/journal.pone.0055963. Epub 2013 Feb 5. PLoS One. 2013. PMID: 23393605 Free PMC article.
References
-
- Abel EL. Effects of marihuana on the solution of anagrams, memory and appetite. Nature 1971;231:260–261. - PubMed
-
- Addicks K, Bloch W, Feelisch M. Nitric oxide modulates sympathetic neurotransmission at the prejunctional level. Microsc Res Tech 1994;29:161–168. - PubMed
-
- Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol 1999;58:315–348. - PubMed
-
- Beal JE, Olson R, Laubenstein L, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 1995;10:89–97. - PubMed
-
- Bloch E, Thysen B, Morrill GA, Gardner E, Fujimoto G. Effects of cannabinoids on reproduction and development. Vitam Horm 1978;36:203–258. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources